RecruitingIschemic StrokeAcute Stroke

Continuous Dual Aspiration Technique With Zoom System for Stroke

Eligible age

18+ yrs

Accepts

All genders

Locations

15 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study is designed to evaluate the effectiveness, safety and clinical performance of ADAPT 2.0, first-line aspiration neurothrombectomy with Zoom System with Continuous Dual Aspiration Technique (CDAT).

Sponsor: Imperative Care, Inc.

You may qualify if…

✓ 1. Subject is ≥ 18 years of age
✓ 2. Subject or legally authorized representative has provided written informed consent prior to any study-specific procedures and no later than 72 hours after the index procedure
✓ 3. Pre-stroke mRS 0-2
✓ 4. Subject is undergoing or has undergone an aspiration thrombectomy using the Zoom System with Continuous Dual Aspiration Technique (CDAT) as the first line device within its intended use

You may not qualify if…

✕ 1. Subjects with a life expectancy of less than 6 months
✕ 2. Female subject who is known to be pregnant at time of admission
✕ 3. Any intracranial hemorrhage in the qualifying head CT or MRI
✕ 4. Presence of tandem internal carotid artery occlusion, multiple occlusion locations (e.g., cavernous ICA and M1, separate M2 occlusions, etc.), or occlusions in multiple territories (e.g., MCA and ACA, bilateral, etc.).
✕ 5. In the opinion of the Investigator, the patient is not a suitable candidate for intervention with the Zoom System
✕ 6. Subject is currently enrolled in or planned to be enrolled in any concurrent interventional study that may impact the safety or performance data collected in this study